Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG). [electronic resource]
Producer: 19980716Description: 1148-58 p. digitalISSN:- 1058-4838
- AIDS-Related Opportunistic Infections -- drug therapy
- Adult
- Antitubercular Agents -- administration & dosage
- Drug Administration Schedule
- Drug Therapy, Combination
- Ethambutol -- administration & dosage
- Female
- Humans
- Isoniazid -- administration & dosage
- Levofloxacin
- Male
- Microbial Sensitivity Tests
- Mycobacterium tuberculosis -- drug effects
- Ofloxacin -- administration & dosage
- Pyrazinamide -- administration & dosage
- Recurrence
- Rifampin -- administration & dosage
- Sputum -- microbiology
- Treatment Outcome
- Tuberculosis, Pulmonary -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.